InvestorsHub Logo
icon url

flipper44

05/01/24 7:59 AM

#688226 RE: exwannabe #688225

In that small trial, the DCVax-l + Poly-ICLC arm showed:

100% unmethylated GBM (idh wildtype) patients lived over two years. (n = 4)

100% methylated GBM (idh wildtype) patient lived over four years. (n = 1)

100% Grade III brain tumor patients are still alive. (Between eight and twelve years). (n = 4)

https://www.researchsquare.com/article/rs-3287211/v1

Yes, the trial did not power itself for survival, but the results in that arm are nonetheless stunning.
icon url

hope4patients

05/01/24 8:00 AM

#688227 RE: exwannabe #688225

Are you familiar with the peer-review process? :)

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
icon url

dstock07734

05/01/24 9:38 AM

#688248 RE: exwannabe #688225

Ned,.
I like this name better.

Is it deliberate that you didn't mention this one?
https://aacrjournals.org/clincancerres/article/17/6/1603/12140/Gene-Expression-Profile-Correlates-with-T-Cell
icon url

Bright Boy

05/08/24 8:31 PM

#689849 RE: exwannabe #688225

I think I will rely on the nature article, rather than you, who is a frayed to reveal your identity! What does that say about your character and reliability on any of your statements?

Cheers,

BB